Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
64
NMPA:64
Drug Approvals
Tropicamide Phenylephrine Eye Drops
- Product Name
- 复方托吡卡胺滴眼液
- Approval Number
- 国药准字H20253245
- Approval Date
- Jan 24, 2025
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20247326
- Approval Date
- Dec 20, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20249048
- Approval Date
- Oct 16, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20243571
- Approval Date
- Apr 24, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20233883
- Approval Date
- Jun 30, 2023
NMPA
Balanced Salt Solution Irrigating
- Product Name
- 平衡盐溶液(供灌注用)
- Approval Number
- 国药准字H20233750
- Approval Date
- Jun 21, 2023
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20233082
- Approval Date
- Jan 19, 2023
NMPA
Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B12 Eye Drops
- Product Name
- 萘敏维滴眼液
- Approval Number
- 国药准字H20227108
- Approval Date
- Aug 25, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found